Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CURX
FEMY
Add up to 3 more stocks
CURX
Curanex Pharmaceuticals Inc Common Stock
+4.64%
$5.19+0.23Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$7.35M
52W Range
$3.58 - $16.94
FEMY
Femasys Inc.
+1.24%
$2.04+0.02Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$6.17M
52W Range
$1.96 - $22.20
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.54 | 1.53 |
| P/S Ratio | N/A | 2.69 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 62.0% |
| Operating Margin | 0.0% | -763.9% |
| Net Margin | 0.0% | -534.3% |
| ROE | -218.7% | -304.8% |
| ROA | -206.3% | -100.0% |
| ROIC | -208.4% | -209.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 45.95 | 2.14 |
| Quick Ratio | 45.95 | 0.55 |
| Debt/Equity | 0.06 | 1.19 |
| Interest Coverage | -496.55 | -9.30 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.